MBI's sales up 2% in first quarter
The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), recorded a 2.2% rise in sales to $2.8 million in the first quarter of 2014. Product sales dropped by 11.6% to $2.1 million, while related party revenues more than doubled from $309,000 to $648,000. Licensing revenues dipped by 6.3% to $45,000. The figures were in line with expectations in view of the adverse impact of severe weather conditions in all growing regions, the company points out.